George Sgouros
George Sgouros
Professor of Radiology and Radiation Sciences, Johns Hopkins University
Verified email at
Cited by
Cited by
MIRD pamphlet no. 21: a generalized schema for radiopharmaceutical dosimetry—standardization of nomenclature
WE Bolch, KF Eckerman, G Sgouros, SR Thomas
Journal of Nuclear Medicine 50 (3), 477-484, 2009
Targeted α particle immunotherapy for myeloid leukemia
JG Jurcic, SM Larson, G Sgouros, MR McDevitt, RD Finn, CR Divgi, ...
Blood, The Journal of the American Society of Hematology 100 (4), 1233-1239, 2002
Radiopharmaceutical therapy in cancer: clinical advances and challenges
G Sgouros, L Bodei, MR McDevitt, JR Nedrow
Nature reviews Drug discovery 19 (9), 589-608, 2020
Radioimmunotherapy with alpha-emitting nuclides
MR McDevitt, G Sgouros, RD Finn, JL Humm, JG Jurcic, SM Larson, ...
European journal of nuclear medicine 25, 1341-1351, 1998
MIRD pamphlet no. 22 (abridged): radiobiology and dosimetry of α-particle emitters for targeted radionuclide therapy
G Sgouros, JC Roeske, MR McDevitt, S Palm, BJ Allen, DR Fisher, ...
Journal of nuclear medicine 51 (2), 311-328, 2010
Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer
Z Szabo, E Mena, SP Rowe, D Plyku, R Nidal, MA Eisenberger, ...
Molecular imaging and biology 17, 565-574, 2015
MIRD pamphlet no. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy
YK Dewaraja, EC Frey, G Sgouros, AB Brill, P Roberson, PB Zanzonico, ...
Journal of Nuclear Medicine 53 (8), 1310-1325, 2012
Prognostic Value of[ 18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid Cancer
W Wang, SM Larson, M Fazzari, SK Tickoo, K Kolbert, G Sgouros, ...
The Journal of Clinical Endocrinology & Metabolism 85 (3), 1107-1113, 2000
2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostateá…
Y Chen, M Pullambhatla, CA Foss, Y Byun, S Nimmagadda, ...
Clinical cancer research 17 (24), 7645-7653, 2011
Bone marrow dosimetry for radioimmunotherapy: theoretical considerations
G Sgouros
Journal of Nuclear Medicine 34 (4), 689-694, 1993
Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software
G Sgouros, KS Kolbert, A Sheikh, KS Pentlow, EF Mun, A Barth, ...
Journal of Nuclear Medicine 45 (8), 1366-1372, 2004
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastaticá…
SY Cho, KL Gage, RC Mease, S Senthamizhchelvan, DP Holt, ...
Journal of Nuclear Medicine 53 (12), 1883-1891, 2012
An α-Particle Emitting Antibody ([213Bi]J591) for Radioimmunotherapy of Prostate Cancer
MR McDevitt, E Barendswaard, D Ma, L Lai, MJ Curcio, G Sgouros, ...
Cancer research 60 (21), 6095-6100, 2000
N-[N-[(S)-1, 3-Dicarboxypropyl] carbamoyl]-4-[18F] fluorobenzyl-L-cysteine,[18F] DCFBC: a new imaging probe for prostate cancer
RC Mease, CL Dusich, CA Foss, HT Ravert, RF Dannals, J Seidel, ...
Clinical Cancer Research 14 (10), 3036-3043, 2008
Sequential cytarabine and α-particle immunotherapy with bismuth-213–lintuzumab (HuM195) for acute myeloid leukemia
TL Rosenblat, MR McDevitt, DA Mulford, N Pandit-Taskar, CR Divgi, ...
Clinical cancer research 16 (21), 5303-5311, 2010
Pharmacokinetics and dosimetry of an α-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia
G Sgouros, ┼M Ballangrud, JG Jurcic, MR McDevitt, JL Humm, YE Erdi, ...
Journal of Nuclear Medicine 40 (11), 1935-1946, 1999
MIRD pamphlet no. 20: the effect of model assumptions on kidney dosimetry and response—implications for radionuclide therapy
BW Wessels, MW Konijnenberg, RG Dale, HB Breitz, M Cremonesi, ...
Journal of Nuclear Medicine 49 (11), 1884-1899, 2008
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity
PC Caron, JG Jurcic, AM Scott, RD Finn, CR Divgi, MC Graham, ...
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.
CR Divgi, NH Bander, AM Scott, JA O'Donoghue, G Sgouros, S Welt, ...
Clinical cancer research: an official journal of the American Associationá…, 1998
MIRD pamphlet no. 19: absorbed fractions and radionuclide S values for six age-dependent multiregion models of the kidney
LG Bouchet, WE Bolch, HP Blanco, BW Wessels, JA Siegel, DA Rajon, ...
Journal of Nuclear Medicine 44 (7), 1113-1147, 2003
The system can't perform the operation now. Try again later.
Articles 1–20